BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4222721)

  • 1. Stimulation of the coronary collateral circulation by lidoflazine (R 7904).
    Schaper WK; Xhonneux R; Jageneau AH
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1965 Nov; 252(1):1-8. PubMed ID: 4222721
    [No Abstract]   [Full Text] [Related]  

  • 2. The systemic and coronary hemodynamic effects of lidoflazine.
    Thomsen JH; Stenlund RR; Corliss RJ; Sialer S; Rowe GG
    Arch Int Pharmacodyn Ther; 1968 Mar; 172(1):15-23. PubMed ID: 5650324
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacology and clinical effects of lidoflazine].
    Janssen PA
    Actual Pharmacol (Paris); 1970; 23():135-61. PubMed ID: 4948983
    [No Abstract]   [Full Text] [Related]  

  • 4. Coronary vasodilator responses to hypoxia and induced tachycardia before and after lidoflazine.
    Afonso S
    Am J Physiol; 1969 Feb; 216(2):297-300. PubMed ID: 5766980
    [No Abstract]   [Full Text] [Related]  

  • 5. The cardiovascular pharmacology of lidoflazine.
    Schaper W; Jageneau A; Xhonneux R
    Brux Med; 1970 Sep; 50(9):635-8. PubMed ID: 5510364
    [No Abstract]   [Full Text] [Related]  

  • 6. Coronary collateral vasodilator action of N-ethoxycarbonyl-3-morpholinosydnonimine (SIN-10) in heart with chronic coronary insufficiency in dogs.
    Hirata M; Kikuchi K
    Jpn J Pharmacol; 1970 Jun; 20(2):187-93. PubMed ID: 5311558
    [No Abstract]   [Full Text] [Related]  

  • 7. The effectiveness of lidoflazine and other coronary vasodilators after oral administration in the trained non-anesthetized dog.
    Jageneau A; Schaper W
    Arzneimittelforschung; 1967 May; 17(5):582-7. PubMed ID: 4969448
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of lidoflazine on coronary circulation and myocardial metabolism in anesthetized and unanesthetized dogs.
    Takenaka T; Tachikawa S
    Arzneimittelforschung; 1970 Mar; 20(3):351-4. PubMed ID: 5467508
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of lidoflazine in atrial muscle.
    Ilhan M; Kayaalp SO
    Arzneimittelforschung; 1973 May; 23(5):640-1. PubMed ID: 4740202
    [No Abstract]   [Full Text] [Related]  

  • 10. Potentiation of adenosine activity by low oral doses of lidoflazine.
    Jageneau AH; Schaper WK
    Nature; 1969 Jan; 221(5176):184-5. PubMed ID: 5782714
    [No Abstract]   [Full Text] [Related]  

  • 11. [Electrocardiographic studies on the drug Clinium].
    Széplaki S; Böszörményi E; Werkner J; Szmandra J
    Orv Hetil; 1974 Jan; 115(1):25-8. PubMed ID: 4809138
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological effects on coronary reactive hyperemia in conscious dogs.
    Juhran W; Voss EM; Dietmann K; Schaumann W
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 269(1):32-47. PubMed ID: 4252441
    [No Abstract]   [Full Text] [Related]  

  • 13. [Coronary vasodilator agents].
    Nakamura Y
    Kokyu To Junkan; 1974 Sep; 22(9):662. PubMed ID: 4475463
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological aspects of the coronary circulation.
    Parratt JR
    Prog Med Chem; 1969; 6():11-66. PubMed ID: 4307053
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of dilating agents on collateral coronary circulation and oxygen tension in the myocardium].
    Sapozhikov AV
    Farmakol Toksikol; 1968; 31(6):687-90. PubMed ID: 5713578
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancement of coronary reactive hyperemia in unanesthetized pigs by an adenosine-potentiator (Lidoflazine).
    Jageneau AH; Schaper WK; Van Gerven W
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 265(1):16-23. PubMed ID: 4254217
    [No Abstract]   [Full Text] [Related]  

  • 17. [Non-homogenous irrigation of the myocardium and its importance in cardiac therapeutics].
    Schaper W
    Brux Med; 1973 Sep; 53(9):523-7. PubMed ID: 4202038
    [No Abstract]   [Full Text] [Related]  

  • 18. Differences among dipyridamole, carbochromen and lidoflazine in responses of the coronary and the renal arteries.
    Sano N; Sato S; Hashimoto K
    Jpn J Pharmacol; 1972 Dec; 22(6):857-65. PubMed ID: 4541491
    [No Abstract]   [Full Text] [Related]  

  • 19. [Efficacy of various coronary dilators following enteral application in the anesthetized dog].
    Lorenz D; Dell HD
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):272-3. PubMed ID: 4242418
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of carbocromen and of other coronary dilator agents on the blood flow of a myocardial ischemic area].
    Faucon G; Ollagnier M; de Claviere M; Kofman J; Evreux JC
    Therapie; 1975; 30(2):185-95. PubMed ID: 1162641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.